Metronomic low-dose regimen of decitabine and venetoclax is safe and reduces monocyte burden in chronic myelomonocytic leukemia
地西他滨和维奈托克的节拍式低剂量方案安全有效,并能降低慢性粒单核细胞白血病中的单核细胞负荷。
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2024.287253
Rockwell, Bradley; Goldfinger, Mendel; Mantzaris, Ioannis; Shastri, Aditi; Saunthararajah, Yogen; Gritsman, Kira; Sica, Alejandro R; Kornblum, Noah; Shah, Nishi; Levitz, David; Shapiro, Lauren C; Gupta, Ridhi; Munoz, Anne; Dhawan, Aradhika; Fehn, Karen; Comas, Monica; Verceles, Jhannine; Cooper, Dennis L; Konopleva, Marina; Feldman, Eric J; Verma, Amit